Executive Dysfunction Clinical Trial
Official title:
Effects of Atomoxetine and Oros-mph on Executive Functions in Patients With Combined Type Attention Deficit Hyperactivity Disorder
The aim of this study was to evaluate and compare the effects of Atomoxetine(ATX) and osmotic release oral system-methylphenidate (OROS-MPH) therapies on executive functions, activities, treatment response time and adverse effects based on discernible clinical effects in children with combined type attention deficit-hyperactivity disorder (ADHD).
The aim of this study was to evaluate and compare the effects of Atomoxetine(ATX) and
osmotic release oral system-methylphenidate (OROS-MPH) therapies on executive functions,
activities, treatment response time and adverse effects based on discernible clinical
effects in children with combined type attention deficit-hyperactivity disorder (ADHD).
In this study, the functional capabilities of the patients who clinically responded well to
therapy were assessed simultaneously with clinical response that may appear at different
time periods and the treatment groups were compared in patients who responded to therapy by
excluding patients with insufficient clinical response.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04111549 -
GOALS Cognitive Training Delivered to Aging Veterans in Person or Via Telehealth
|
N/A | |
| Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
| Enrolling by invitation |
NCT05017779 -
A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth
|
N/A | |
| Terminated |
NCT02416193 -
Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)
|
Phase 2 | |
| Recruiting |
NCT06073717 -
Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT).
|
N/A | |
| Completed |
NCT02613936 -
Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury
|
N/A | |
| Recruiting |
NCT05874791 -
Executive Control Training for Adolescents With ADHD: A Randomized Controlled Effectiveness Trial
|
N/A | |
| Recruiting |
NCT04465708 -
HOPS Study: A Conceptual Replication
|
N/A | |
| Active, not recruiting |
NCT05131659 -
Intervention-Induced Plasticity of Flexibility and Learning Mechanisms in ASD
|
N/A | |
| Active, not recruiting |
NCT04121650 -
Executive Function and Symptom Reduction in Youth Receiving Home-based Treatment With Collaborative Problem Solving
|
||
| Completed |
NCT04221841 -
Executive Functions and Reinforcement Sensitivity in Women With Obsessive Compulsive Symptoms
|
||
| Completed |
NCT03285347 -
Effect of Computer-based Cognitive Training on Attention and Executive Functions in Patients With Parkinson's Disease
|
N/A | |
| Completed |
NCT03490110 -
Brain Markers of Improvements in Cognitive Functioning
|
N/A | |
| Completed |
NCT03073122 -
The Boston Circulatory Arrest Study: Antecedents and Correlates of Well-Being in Adults With Congenital Heart Disease
|
||
| Completed |
NCT03958487 -
An Executive/Monitoring Treatment Protocol on Everyday Life Activities
|
N/A | |
| Completed |
NCT02091284 -
Bilateral Prefrontal Modulation in Alcoholism
|
N/A | |
| Completed |
NCT02091167 -
Bilateral Prefrontal Modulation in Crack-cocaine Addiction
|
Phase 2 | |
| Completed |
NCT01730261 -
Online Emotional Regulation Group Treatment
|
Phase 1 | |
| Completed |
NCT00271596 -
Citalopram to Enhance Cognition in HD
|
Phase 2 | |
| Active, not recruiting |
NCT04108728 -
Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )
|
N/A |